Cargando…

IL-6/JAK/STAT3介导苦参碱对K562细胞的增殖抑制作用

OBJECTIVE: To investigate the molecular mechanism of the growth inhibitory effect of matrine on K562 cells in JAK/STAT3 mediated signal pathway. METHODS: Western blot analyses were performed to investigate the differential expression of JAK2, STAT3, phospho-STAT3 (Tyr705 & Ser727) and phospho-JA...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342599/
https://www.ncbi.nlm.nih.gov/pubmed/26031532
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.05.015
Descripción
Sumario:OBJECTIVE: To investigate the molecular mechanism of the growth inhibitory effect of matrine on K562 cells in JAK/STAT3 mediated signal pathway. METHODS: Western blot analyses were performed to investigate the differential expression of JAK2, STAT3, phospho-STAT3 (Tyr705 & Ser727) and phospho-JAK2 proteins after matrine treatment in K562 cells with or without human recombinant interleukin 6 (IL-6) pretreatment. The expressions of STAT3 response gene products such as Bcl-xL, Cyclin D1 and c-Myc, were investigated by Western blot and quantitative real time RT-PCR (qRT-PCR). Expression of IL-6, a potent upstream activating factor of JAK/STAT3 pathway, was analyzed by both real time qRT-PCR and ELISA. RESULTS: Western blot revealed that matrine treatment resulted in a strong down-regulation of phospho-STAT3 both in Tyr705 and Ser727 sites or phospho-JAK2 proteins expression without significant effects on the total STAT3 and JAK2 proteins. The expression of phospho-Tyr705 STAT3 and phospho-Ser727 STAT3 was decreased to 0.370±0.024 and 0.700±0.172 in K562 cells treated with 0.5 mg/ml matrine for 48 h, respectively, from 0.690 ± 0.119 and 1.150 ± 0.263 in control cells, accompanied with a dramatical down-regulation of phospho-JAK2 from 0.670±0.137 to 0.049±0.057 (P< 0.05). In addition, it was found that the expression of Bcl-xL, Cyclin D1, c-Myc was decreased both at the transcriptional and protein level in K562 cells after matrine treatment. Matrine treatment resulted in a significant decrease in the expression level of IL-6 in K562 cells from (35.1±1.93) to (10.74±1.83) and (8.66±1.24) pg/ml at the dose of 0.5 and 0.8 mg/ml, respectively (P<0.05). Matrine treatment could diminish the up-regulation of STAT3, JAK2, phospho-STAT3 and phospho-JAK2 protein following pretreatment with IL-6 in K562 cells. CONCLUSION: Matrine exerts its anti-leukemia effect by interfering with the JAK2/STAT3 signaling pathway. The inhibition of IL-6 expression may play a pivotal role in the disruption of JAK/STAT pathway by matrine.